Tekla Capital Management LLC Exact Sciences Corp Transaction History

Tekla Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $16.3 Million - $22.7 Million	-225,282 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $2.31 Million - $3.18 Million	25,628 Added 12.84%	225,282 $21.5 Million
Q2 2021 Aug 13, 2021	BUY	$93.66 - $139.27 $3.03 Million - $4.51 Million	32,352 Added 19.34%	199,654 $24.8 Million
Q1 2021 May 14, 2021	BUY	$116.57 - $155.01 $12.1 Million - $16.1 Million	103,800 Added 163.46%	167,302 $22 Million
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $4.82 Million - $6.87 Million	48,352 Added 319.16%	63,502 $8.41 Million
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $2.1 Million - $2.94 Million	-28,865 Reduced 65.58%	15,150 $1.55 Million
Q2 2020 Aug 13, 2020	BUY	$55.75 - $92.75 $1.16 Million - $1.94 Million	20,882 Added 90.27%	44,015 $3.83 Million
Q1 2020 May 14, 2020	BUY	$37.9 - $104.44 $876,740 - $2.42 Million	23,133 New	23,133 $1.34 Million

610

166M

1.93M

1.23M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.7B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.